Skip to main content
Top

11-14-2018 | Charcot foot | Article

Varied presentations and outcomes of Charcot neuroarthropathy in patients with diabetes mellitus

Journal: International Journal of Diabetes in Developing Countries

Authors: Ashu Rastogi, Mahesh Prakash, Anil Bhansali

Publisher: Springer India

Abstract

Charcot neuroarthropathy (CN) of the foot is uncommon and CN of atypical sites like wrist is sparingly described. CN is grossly under-diagnosed or misdiagnosed by primary care physicians. CN may present in acute phase with classical signs of inflammation or with deformities in chronic phase. The present study describes varied presentations, diagnostic dilemmas, and outcomes of CN in patients with diabetes. Data from the electronic repository of patients with diabetes and foot complications was obtained. The repository has a pre-designed structured format for information pertaining to the patients’ anthropometry, presentation, neurological, vascular and foot examination details, treatment offered, and outcomes on follow-up. In addition, literature search for prior reported cases of atypical site (wrist) of CN was conducted. Data of 206 subjects with foot CN and two cases of atypical joint amongst 1297 patients with diabetes mellitus was screened. The particulars of patients with varied presentation viz. acute phase (case 1), stable foot deformities in chronic phase (case 2), and unstable foot with destruction of ankle joint in hindfoot CN (case 3) are presented along with the differential diagnosis and their outcomes on follow-up at 36 months of presentation. A literature search for atypical site of CN revealed only nine cases of wrist CN. The diagnosis of wrist CN was not initially considered and misdiagnosed. Patient with CN may present in active phase or more commonly with deformities and destroyed joints. The acute CN is misdiagnosed as cellulitis and inadvertently treated with antibiotics. Wrist and MCP joint CN is extremely rare and the diagnosis of CN requires a high index of suspicion supported by radiography findings.
Literature
1.
Fabrin J, Larsen K, Holstein PE. Long-term follow-up in diabetic Charcot feet with spontaneous onset. Diabetes Care. 2000;23:796–800.CrossRefPubMed
2.
Jeffcoate WJ. Charcot foot syndrome. Diabet Med. 2015;32(6):760–70.CrossRefPubMed
3.
Cavangh PR, Young MJ, Adams JE, Vickers KL, Boulton AJ. Radiographic abnormalities in the feet of patients with diabetic neuropathy. Diabetes Care. 1994;17:201–9.CrossRef
4.
Bhansali A, Dutta P, Bhatt MH, Singh P, Aggrawal A, Mittal BR. The Charcot neuroarthropathy of the elbow in type 2 diabetes mellitus. Endocrinologist. 2009;19:171–3.CrossRef
5.
Feldman MJ, Becker KL, Reefe WE, Longo A. Multiple neuropathic joints, including the wrist in a patient with diabetes mellitus. JAMA. 1969;209:1690–2.CrossRefPubMed
6.
Bayne O, Lu EJ. Diabetic Charcot’s arthropathy of the wrist. Case report and literature review. Clin Orthop Relat Res. 1998;357:122–6.CrossRef
7.
Lambert PA, Close CF. Charcot neuroarthropathy of the wrist in type 1 diabetes. Diabetes Care. 2005;28:984–5.CrossRefPubMed
8.
Wŕobel M, Szymborska-Kajanek A, Skiba M, et al. Charcot’s joint of the wrist in type 2 diabetes mellitus. Exp Clin Endocrinol Diabetes. 2007;115:55–7.CrossRefPubMed
9.
Gökhan C¸ Erkan K¸ Levent Ö. Acute Charcot arthropathy of wrist in a diabetic patient. Rheumatol Int 2013 33:2959–2960.CrossRef
10.
Illgner U, Netten JV, Droste C, Meiners T, Postema K, Wetz HH. Diabetic Charcot neuroarthropathy of the hand: clinical course, diagnosis and treatment options. Diabetes Care. 2014;37:e91–2.CrossRefPubMed
11.
Pakarinen TK, Laine HJ, Honkonen SE, Peltonen J, Oksala H, Lahtela J. Charcot arthropathy of the diabetic foot: current concepts and review of 36 cases. Scand J Surg. 2002;91:195–201.CrossRefPubMed
12.
Sinha S, Munichoodappa C, Kozak GP. Neuroarthropathy Charcot’s joint in diabetes mellitus: a clinical study of 101 cases. Medicine (Baltimore). 1972;51:192–210.CrossRef
13.
Eichenholtz SN. Charcot joints. Springfield: Charles C, Thomas; 1966. p. 7–8.
14.
Perkins BA, Olaleye D, Bril V. Carpal tunnel syndrome in patients with diabetic polyneuropathy. Diabetes Care. 2002;25:565–9.CrossRefPubMed
15.
Dyck P, Kratz K, Karnes J, Litchy W, Klein R, Pach J, et al. The prevalence by staged severity of various types of diabetic neuropathy, retinopathy, and nephropathy in a population-based cohort: the Rochester Diabetic Neuropathy Study. Neurology. 1993;43:817–24.CrossRefPubMed
16.
Harden RN, Oaklander AL, Burton AW, Perez RS, Richardson K, Swan M, et al. Complex regional pain syndrome: practical diagnostic and treatment guidelines. 4th edition. Pain Med. 2013;14:180–229.CrossRefPubMed
17.
Harden RN, Bruehl S, Perez RS, Birklein F, Marinus J, Maihofner C, et al. Validation of proposed diagnostic criteria (the “Budapest criteria”) for complex regional pain syndrome. Pain. 2010;150:268–74.CrossRefPubMedPubMedCentral
18.
Charcot JM. Sur quelques arthropathies qui paraissent dépendre d’une lésion du cerveau ou de la moëlle épinière. Arch Physiol Norm Pathol. 1868;1:161–78.
19.
Jordan WR. Neuritic manifestations in diabetes mellitus. Arch Intern Med. 1936;57:307–58.CrossRef
20.
Chisholm KA, Gilchrist JM. The Charcot joint: a modern neurologic perspective. J Clin Neuromuscul Dis. 2011;13:1–13.CrossRefPubMed
21.
Jeffcoate W, Lipsky BA. Controversies in diagnosing and managing osteomyelitis of the foot in diabetes. Clin Infect Dis. 2004;39(Suppl 2):S115–22.CrossRefPubMed
22.
Game FL, Catlow R, Jones GR, Edmonds ME, Jude EB, Rayman G, et al. Audit of acute Charcot’s disease in the UK: the CDUK study. Diabetologia. 2012;55:32–5.CrossRefPubMed
23.
Wang L, Shi X, Zhao R, Halloran BP, Clark DJ. Calcitonin- gene-related peptide stimulates stromal cell osteogenic differentiation and inhibits RANKL induced NF-kappa B activation, osteoclastogenesis and bone resorption. Bone. 2010;46:1369–79.CrossRefPubMed
24.
Ndip A, Williams A, Jude EB, Serracino-Inglott F. The RANKL/RANK/OPG signaling pathway mediates medial arterial calcification in diabetic Charcot neuroarthropathy. Diabetes. 2011;60:2187–96.CrossRefPubMedPubMedCentral
25.
Jude EB, Selby PL, Burgess J, Lilleystone P, Mawer EB, Page SR, et al. Bisphosphonates in the treatment of Charcot neuroarthropathy: a double-blind randomised controlled trial. Diabetologia. 2001;44:2032–7.CrossRefPubMed
26.
Pakarinen T-K, Laine H-J, Maenpaa H, Mattila P, Lahtela J. The effect of zoledronic acid on the clinical resolution of Charcot neuroarthropathy. Diabetes Care. 2011;34:1514–6.CrossRefPubMedPubMedCentral
27.
Richard JL, Almasari M, Schuldiner S. Treatment of acute Charcot foot with bisphosphonates: a systematic review of the literature. Diabetologia. 2012;55:1258–64.CrossRefPubMed

Be confident that your patient care is up to date

Medicine Matters is being incorporated into Springer Medicine, our new medical education platform. 

Alongside the news coverage and expert commentary you have come to expect from Medicine Matters diabetes, Springer Medicine's complimentary membership also provides access to articles from renowned journals and a broad range of Continuing Medical Education programs. Create your free account »